{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:12:10Z","timestamp":1791807130813,"version":"4.3.4"},"reference-count":73,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.clml.2020.08.023","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T11:39:53Z","timestamp":1600429193000},"page":"e85-e98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Systematic Review of the Burden and Treatment Patterns of Adult and Adolescent Acute Lymphoblastic Leukemia in India: Comprehending the Challenges in an Emerging Economy"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9484-5669","authenticated-orcid":false,"given":"Vivek S.","family":"Radhakrishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8743-1801","authenticated-orcid":false,"given":"Narendra","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhausaheb","family":"Bagal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2020.08.023_bib1","doi-asserted-by":"crossref","first-page":"e577","DOI":"10.1038\/bcj.2017.53","article-title":"Acute lymphoblastic leukemia: a comprehensive review and 2017 update","volume":"7","author":"Terwilliger","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2020.08.023_bib2","first-page":"1627","article-title":"Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden","volume":"26","author":"Katz","year":"2015","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clml.2020.08.023_bib3","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1200\/GO.20.00122","article-title":"Cancer Statistics, 2020: report from national cancer registry programme, India","volume":"6","author":"Mathur","year":"2020","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.clml.2020.08.023_bib4","first-page":"2885","article-title":"Population based cancer registry of India\u2014the challenges and opportunities","volume":"19","author":"Behera","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clml.2020.08.023_bib5","first-page":"13","article-title":"Cancer registration in India","volume":"2","author":"Gajalakshmi","year":"2001","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clml.2020.08.023_bib7","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia","volume":"381","author":"Inaba","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2020.08.023_bib8","doi-asserted-by":"crossref","first-page":"v69","DOI":"10.1093\/annonc\/mdw025","article-title":"Acute lymphoblastic leukaemia in adult patients: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Hoelzer","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2020.08.023_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/10428199109067628","article-title":"Acute lymphoblastic leukaemia in adults: prognostic factors and 10 year treatment results","volume":"5","author":"Bezwoda","year":"1991","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2020.08.023_bib10","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","article-title":"Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the Children\u2019s Oncology Group","volume":"30","author":"Hunger","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.08.023_bib11","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1056\/NEJMoa0900386","article-title":"Treating childhood acute lymphoblastic leukemia without cranial irradiation","volume":"360","author":"Pui","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2020.08.023_bib12","doi-asserted-by":"crossref","first-page":"55181","DOI":"10.18632\/oncotarget.10473","article-title":"Serum neuron-specific enolase levels are upregulated in patients with acute lymphoblastic leukemia and are predictive of prognosis","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.clml.2020.08.023_bib13","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/cncr.29383","article-title":"New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia","volume":"121","author":"Jabbour","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2020.08.023_bib14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1200\/JCO.2010.30.1382","article-title":"Modern therapy of acute lymphoblastic leukemia","volume":"29","author":"Bassan","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.08.023_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood-2011-04-347872","article-title":"Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007","volume":"119","author":"Dores","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.08.023_bib16","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1182\/blood-2005-04-1623","article-title":"Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII\/ECOG E2993","volume":"106","author":"Rowe","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.08.023_bib17","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1182\/blood-2009-08-231217","article-title":"T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII\/ECOG 2993)","volume":"114","author":"Marks","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.08.023_bib18","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2020.08.023_bib19","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S1470-2045(18)30447-9","article-title":"The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016","volume":"19","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2020.08.023_bib20","first-page":"103","article-title":"Financial burden of therapy in families with a child with acute lymphoblastic leukemia: report from north India","volume":"24","author":"Ghatak","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clml.2020.08.023_bib22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13045-020-00905-2","article-title":"Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions","volume":"13","author":"Samra","year":"2020","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.clml.2020.08.023_bib23","first-page":"1","article-title":"Leukaemias at Pondicherry","volume":"18","author":"Prakash","year":"1981","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.clml.2020.08.023_bib24","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0145-2126(85)90315-7","article-title":"Pattern of subtypes of acute lymphoblastic leukemia in India","volume":"9","author":"Kamat","year":"1985","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2020.08.023_bib25","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0145-2126(85)90295-4","article-title":"Leukaemias and lymphomas at Lucknow, India","volume":"9","author":"Kushwaha","year":"1985","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2020.08.023_bib26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0145-2126(88)90102-6","article-title":"Immunological subtypes of acute lymphoblastic leukemia in north India","volume":"12","author":"Bhargava","year":"1988","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2020.08.023_bib27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ajh.20000","article-title":"Paucity of TEL-AML 1 translocation, by multiplex RT-PCR, in B-lineage acute lymphoblastic leukemia (ALL) in Indian patients","volume":"76","author":"Sazawal","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2020.08.023_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12288-008-0016-9","article-title":"Hematological malignancies diagnosed by bone marrow examination in a tertiary hospital at Uttarakhand, India","volume":"24","author":"Kusum","year":"2008","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.clml.2020.08.023_bib29","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1182\/blood.V118.21.4234.4234","article-title":"Detection of common chimeric fusion transcripts in acute lymphoblastic leukemia (ALL) patients using multiplex reverse transcriptase polymerase chain reaction assay: a North Indian tertiary care centre experience","volume":"118","author":"Varma","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.08.023_bib30","first-page":"175","article-title":"Pattern of leukaemias in a tertiary care hospital \u2014a 5 years retrospective study of 103 cases","author":"Laishram","year":"2013","journal-title":"Indian Med Gazette"},{"key":"10.1016\/j.clml.2020.08.023_bib31","first-page":"278","article-title":"Clinical profile of relapsed acute lymphoblastic leukemia patients: a single center experience","volume":"29","author":"Roshan","year":"2013","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.clml.2020.08.023_bib32","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1182\/blood.V126.23.2620.2620","article-title":"Prognostic significance of immunophenotypic composition of B cell acute lymphoblastic leukemia at diagnosis: a novel immunophenotype based risk score","volume":"126","author":"Deshpande","year":"2015","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1016\/j.clml.2020.08.023_bib33","doi-asserted-by":"crossref","first-page":"i234","DOI":"10.1093\/ije\/dyv096.416","article-title":"A\u00a0study of incidence of recurrent genetic translocations in adult and pediatric acute lymphoblastic","volume":"44","author":"Varma","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.clml.2020.08.023_bib34","first-page":"530","article-title":"Cytogenetic profile in 7209 Indian patients with de novo acute leukemia: a single centre study from India","volume":"7","author":"Amare","year":"2016","journal-title":"J\u00a0Cancer Ther"},{"key":"10.1016\/j.clml.2020.08.023_bib35","doi-asserted-by":"crossref","first-page":"710","DOI":"10.5958\/2394-6792.2016.00132.0","article-title":"Incidence of acute and chronic leukemias in rural area at tertiary care teaching hospital: a five years of study","volume":"3","author":"Baviskar","year":"2016","journal-title":"Indian J Pathol Oncol"},{"key":"10.1016\/j.clml.2020.08.023_bib36","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.18203\/2320-6012.ijrms20160792","article-title":"Spectrum of acute and chronic leukemia at a tertiary care hospital, Haryana. India","volume":"4","author":"Singh","year":"2016","journal-title":"Int J Res Med Sci"},{"key":"10.1016\/j.clml.2020.08.023_bib37","doi-asserted-by":"crossref","first-page":"563","DOI":"10.21474\/IJAR01\/6473","article-title":"Cytogenetics findings of patients with acute lymphoblastic leukemia in West Indian region","volume":"6","author":"Gadhia","year":"2018","journal-title":"Int J Adv Res"},{"key":"10.1016\/j.clml.2020.08.023_bib38","doi-asserted-by":"crossref","first-page":"e2019017","DOI":"10.4084\/mjhid.2019.017","article-title":"Spectrum and immunophenotypic profile of acute leukemia: a tertiary center flow cytometry experience","volume":"11","author":"Gupta","year":"2019","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.clml.2020.08.023_bib39","doi-asserted-by":"crossref","first-page":"10046","DOI":"10.1200\/jco.2009.27.15_suppl.10046","article-title":"Result of adolescent acute lymphoblastic leukemia protocol (MCP 841) from a developing country","volume":"27","author":"Mukhopadhyay","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.08.023_bib40","doi-asserted-by":"crossref","first-page":"545","DOI":"10.9734\/JSRR\/2014\/4044","article-title":"Study of clinico-hematological and immunophenotypic profile in adult patients with acute lymphoblastic leukemia in Eastern India","volume":"23","author":"Bhattacharyya","year":"2014","journal-title":"J\u00a0Sci Res Rep"},{"key":"10.1016\/j.clml.2020.08.023_bib41","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3109\/10428194.2013.814130","article-title":"Outcome of treatment with a low cost protocol in adults with T cell acute lymphoblastic leukemia in a tertiary care center in India","volume":"55","author":"Abraham","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2020.08.023_bib42","first-page":"372","article-title":"Acute lymphoblastic leukemia in northern India","volume":"4","author":"Khan","year":"2015","journal-title":"Indian J Basic Appl Med Res"},{"issue":"suppl 1","key":"10.1016\/j.clml.2020.08.023_bib43","first-page":"S28","article-title":"Treatment of adolescent and young adults with newly diagnosed non-Philadelphia positive acute lymphoblastic leukemia with pediatric protocol: a single centre experience","volume":"33","author":"Agrawal","year":"2017","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.clml.2020.08.023_bib44","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1182\/blood-2018-99-114640","article-title":"AYA ALL: real world experience from a tertiary care center in North India","volume":"132","author":"Das","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.08.023_bib45","first-page":"1","article-title":"Adult acute lymphoblastic leukemia: limitations of intensification of therapy in a developing country","volume":"4","author":"Jain","year":"2018","journal-title":"J\u00a0Glob Oncol"},{"issue":"suppl 1","key":"10.1016\/j.clml.2020.08.023_bib46","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1182\/blood-2019-127091","article-title":"Outcomes in adolescent and young adult (AYA) acute lymphoblastic leukemia (ALL): a report from the Indian Acute Leukemia Research Database (INwARD) of the Hematology Cancer Consortium (HCC)","volume":"134","author":"Ganesan","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.08.023_bib47","first-page":"5006","article-title":"Outcome of BCR-ABL\/Philadelphia positive acute lymphoblastic leukemia: a single centre experience from developing country","volume":"130","author":"Agrawal","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.08.023_bib48","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1182\/blood.V110.11.4339.4339","article-title":"Imatinib plus vincristine and prednisolone induces complete remission and prolonged survival in elderly Philadelphia chromosome positive acute lymphoblastic leukemia patients","volume":"110","author":"Mukhopadhyay","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.08.023_bib49","first-page":"278","article-title":"Treatment outcomes in Ph+ ALL\u2014a single centre experience","volume":"29","author":"Dangi","year":"2013","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.clml.2020.08.023_bib50","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s12288-017-0892-y","article-title":"Acute lymphoblastic leukemia in young adults treated with intensive \u201cpediatric\u201d type protocol","volume":"34","author":"Ganesan","year":"2018","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.clml.2020.08.023_bib51","article-title":"Comparison of treatment outcomes with HYPER CVAD and MCP-841 in acute lymphoblastic leukemia (ALL)\u2014a retrospective analysis","volume":"248","author":"Sadique","year":"2018","journal-title":"Haematocon"},{"issue":"suppl 2","key":"10.1016\/j.clml.2020.08.023_bib52","first-page":"S483","article-title":"Metronomic therapy with oral 6-mercaptopurine and prednisolone in relapsed acute lymphoblastic leukemia in elderly patients: a prospective study","volume":"30","author":"Kapoor","year":"2014","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.clml.2020.08.023_bib53","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1182\/blood.V126.23.3761.3761","article-title":"Thiopurine methyl transferase (TPMT) activity and erythrocyte thioguanine nucleotide levels are reliable markers of tolerability to 6-mercaptopurine in adult acute lymphoblastic leukemia","volume":"126","author":"Sengar","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.08.023_bib54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/10428199409049680","article-title":"Adult acute lymphoblastic leukemia: results of an aggressive regimen in India","volume":"14","author":"Raje","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2020.08.023_bib55","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ajh.10211","article-title":"Randomized study comparing 4-epi-doxorubicin (Epirubicin) versus doxorubicin as a part of induction treatment in adult acute lymphoblastic leukemia","volume":"71","author":"Bhutani","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2020.08.023_bib56","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1038\/sj.leu.2404785","article-title":"Adult ALL: treatment outcome and prognostic factors in an Indian population using a modified German ALL (GMALL) protocol","volume":"21","author":"Bajel","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2020.08.023_bib57","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1080\/10428190701343255","article-title":"Outcome of adult acute lymphoblastic leukemia with BFM protocol in a resource-constrained setting","volume":"48","author":"Malhotra","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2020.08.023_bib58","first-page":"240","article-title":"Outcomes for adult Philadelphia positive acute lymphoblastic leukemia\u2014experience from a tertiary cancer centre","volume":"35","author":"Sengar","year":"2019","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.clml.2020.08.023_bib59","first-page":"S430","article-title":"Acute lymphoblastic leukemia presenting as pancytopenia: clinical characteristics and treatment outcome","volume":"32","author":"Nambiar","year":"2016","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.clml.2020.08.023_bib60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/ijc.IJC_656_17","article-title":"Long term clinical outcomes of adult hematolymphoid malignancies treated at Tata Memorial Hospital: an institutional audit","volume":"55","author":"Khattry","year":"2018","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.clml.2020.08.023_bib61","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1182\/blood.V122.21.1404.1404","article-title":"Trends in survival outcome of elderly patients with B-lineage acute lymphoblastic leukemia: analysis of SEER database","volume":"122","author":"Guru Murthy","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.08.023_bib62","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12288-018-1005-2","article-title":"Outcome of Philadelphia positive acute lymphoblastic leukemia with or without allogeneic stem cell transplantation in a retrospective study","volume":"35","author":"Agrawal","year":"2019","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.clml.2020.08.023_bib63","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s12288-019-01091-z","article-title":"Study of haploidentical stem cell transplantation for Philadelphia\/BCR-ABL positive acute lymphoblstic leukemia","volume":"35","author":"Agrawal","year":"2019","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.clml.2020.08.023_bib64","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1002\/cam4.2096","article-title":"The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: an IMPACT cohort study","volume":"8","author":"Gupta","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.clml.2020.08.023_bib65","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1002\/cncr.26033","article-title":"Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006","volume":"117","author":"Juliusson","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2020.08.023_bib66","first-page":"13","article-title":"Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time\u2014a report of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)","volume":"17","author":"Frassoni","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2020.08.023_bib67","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1008366814109","article-title":"Acute lymphoblastic leukemia in India: an analysis of prognostic factors using a single treatment regimen","volume":"10","author":"Advani","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2020.08.023_bib68","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1756-8722-5-29","article-title":"Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"5","author":"Chen","year":"2012","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.clml.2020.08.023_bib69","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13045-017-0480-5","article-title":"Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT","volume":"10","author":"Santoro","year":"2017","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.clml.2020.08.023_bib70","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbmt.2016.11.008","article-title":"Haploidentical transplantation with post-transplantation cyclophosphamide for high-risk acute lymphoblastic leukemia","volume":"23","author":"Srour","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2020.08.023_bib71","first-page":"53","article-title":"A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL)","volume":"14","author":"Radaelli","year":"2005","journal-title":"Eur J Cancer Care (Engl)."},{"key":"10.1016\/j.clml.2020.08.023_bib72","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1182\/blood-2003-08-2958","article-title":"Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate","volume":"103","author":"Thomas","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.08.023_bib74","unstructured":"Modak K, et\u00a0al. Bridging RR-ALL (relapsed\/refractory acute lymphoblastic leukemia) to allogenic haematopoietic cell transplant (HCT) using inotuzumab ozogamicin. Poster presented at HEMATOCON 2018."},{"key":"10.1016\/j.clml.2020.08.023_bib75","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/bjh.16005","article-title":"Efficacy and safety of a bortezomib and reduced-intensity cytarabine-based protocol, TMC ALLR1, for relapsed childhood ALL in India","volume":"186","author":"Roy","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2020.08.023_bib76","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13045-020-00905-2","article-title":"Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions","volume":"13","author":"Samra","year":"2020","journal-title":"J\u00a0Hematol Oncol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020305139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020305139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:35:42Z","timestamp":1761870942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265020305139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2152265020305139"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2020.08.023","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic Review of the Burden and Treatment Patterns of Adult and Adolescent Acute Lymphoblastic Leukemia in India: Comprehending the Challenges in an Emerging Economy","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2020.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}